Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-06-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1225522/full |
| _version_ | 1797813388743540736 |
|---|---|
| author | Laura Grohs Laura Grohs Linhan Cheng Saskia Cönen Saskia Cönen Bassam G. Haddad Astrid Bülow Astrid Bülow Idil Toklucu Lisa Ernst Jannis Körner Jannis Körner Günther Schmalzing Angelika Lampert Jan-Philipp Machtens Jan-Philipp Machtens Ralf Hausmann |
| author_facet | Laura Grohs Laura Grohs Linhan Cheng Saskia Cönen Saskia Cönen Bassam G. Haddad Astrid Bülow Astrid Bülow Idil Toklucu Lisa Ernst Jannis Körner Jannis Körner Günther Schmalzing Angelika Lampert Jan-Philipp Machtens Jan-Philipp Machtens Ralf Hausmann |
| author_sort | Laura Grohs |
| collection | DOAJ |
| first_indexed | 2024-03-13T07:52:13Z |
| format | Article |
| id | doaj.art-9482c43516cd4194b15dbe85cd4ab421 |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-03-13T07:52:13Z |
| publishDate | 2023-06-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-9482c43516cd4194b15dbe85cd4ab4212023-06-02T14:31:24ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-06-011410.3389/fphar.2023.12255221225522Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptorLaura Grohs0Laura Grohs1Linhan Cheng2Saskia Cönen3Saskia Cönen4Bassam G. Haddad5Astrid Bülow6Astrid Bülow7Idil Toklucu8Lisa Ernst9Jannis Körner10Jannis Körner11Günther Schmalzing12Angelika Lampert13Jan-Philipp Machtens14Jan-Philipp Machtens15Ralf Hausmann16Institute of Clinical Pharmacology, RWTH Aachen University, Aachen, GermanyDepartment of Neurology, University Hospital, RWTH Aachen University, Aachen, GermanyInstitute of Clinical Pharmacology, RWTH Aachen University, Aachen, GermanyInstitute of Clinical Pharmacology, RWTH Aachen University, Aachen, GermanyMolecular and Cellular Physiology (IBI-1), Institute of Biological Information Processing (IBI), Jülich, GermanyMolecular and Cellular Physiology (IBI-1), Institute of Biological Information Processing (IBI), Jülich, GermanyInstitute of Clinical Pharmacology, RWTH Aachen University, Aachen, GermanyDepartment of Plastic Surgery, Hand and Burn Surgery, University Hospital RWTH Aachen, Aachen, GermanyInstitute of Physiology (Neurophysiology), RWTH Aachen University, Aachen, GermanyInstitute for Laboratory Animal Science and Experimental Surgery, RWTH Aachen University, Aachen, GermanyInstitute of Physiology (Neurophysiology), RWTH Aachen University, Aachen, GermanyDepartment of Anesthesiology, University Hospital RWTH Aachen, Aachen, GermanyInstitute of Clinical Pharmacology, RWTH Aachen University, Aachen, GermanyInstitute of Physiology (Neurophysiology), RWTH Aachen University, Aachen, GermanyInstitute of Clinical Pharmacology, RWTH Aachen University, Aachen, GermanyMolecular and Cellular Physiology (IBI-1), Institute of Biological Information Processing (IBI), Jülich, GermanyInstitute of Clinical Pharmacology, RWTH Aachen University, Aachen, Germanyhttps://www.frontiersin.org/articles/10.3389/fphar.2023.1225522/fullP2X3 receptornociceptionchronic painnon-steroidal anti-inflammatory drugs (NSAIDs)competitive antagonistdrug screening |
| spellingShingle | Laura Grohs Laura Grohs Linhan Cheng Saskia Cönen Saskia Cönen Bassam G. Haddad Astrid Bülow Astrid Bülow Idil Toklucu Lisa Ernst Jannis Körner Jannis Körner Günther Schmalzing Angelika Lampert Jan-Philipp Machtens Jan-Philipp Machtens Ralf Hausmann Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor Frontiers in Pharmacology P2X3 receptor nociception chronic pain non-steroidal anti-inflammatory drugs (NSAIDs) competitive antagonist drug screening |
| title | Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor |
| title_full | Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor |
| title_fullStr | Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor |
| title_full_unstemmed | Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor |
| title_short | Corrigendum: Diclofenac and other non-steroidal anti-inflammatory drugs (NSAIDs) are competitive antagonists of the human P2X3 receptor |
| title_sort | corrigendum diclofenac and other non steroidal anti inflammatory drugs nsaids are competitive antagonists of the human p2x3 receptor |
| topic | P2X3 receptor nociception chronic pain non-steroidal anti-inflammatory drugs (NSAIDs) competitive antagonist drug screening |
| url | https://www.frontiersin.org/articles/10.3389/fphar.2023.1225522/full |
| work_keys_str_mv | AT lauragrohs corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT lauragrohs corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT linhancheng corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT saskiaconen corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT saskiaconen corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT bassamghaddad corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT astridbulow corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT astridbulow corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT idiltoklucu corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT lisaernst corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT janniskorner corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT janniskorner corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT guntherschmalzing corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT angelikalampert corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT janphilippmachtens corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT janphilippmachtens corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor AT ralfhausmann corrigendumdiclofenacandothernonsteroidalantiinflammatorydrugsnsaidsarecompetitiveantagonistsofthehumanp2x3receptor |